AT&T's $177 million settlement is for data breaches in 2019 and 2024. Claim up to $5,000 (first breach) and $2,500 (Snowflake hack), or both. File your claim by Dec. 18, 2025, either online or by mail ...

Last week Nvidia finally got permission to sell one of its most advanced semiconductor chips to China. The catch: The federal government will take 25% of the revenue from those sales. The Nvidia deal ...

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, a much smaller potential rival ...

Just when you thought you heard it all, AI systems designed to spot cancer have startled researchers with a baked-in penchant for racism. The alarming findings were published in the journal Cell ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

A frenetic morning of biotech news on Monday is weighing on the stocks of Novo Nordisk and Eli Lilly, the two behemoths of the obesity market. First came new data from Structure Therapeutics, an ...

Structure Therapeutics is also advancing aleniglipron, an oral GLP-1 receptor agonist that recently completed Phase 2 clinical trials. The clinical advancement of ACCG-2671 comes as pharmaceutical ...

A frenetic morning of biotech news on Monday is weighing on the stocks of Novo Nordisk and Eli Lilly, the two behemoths of the obesity market.